Salem Capital Management’s AbbVie ABBV Stock Holding History

Salem Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	$255K	Hold	1,900	–	–	0.2%	50
2022 Q2	$291K	Hold	1,900	–	–	0.21%	50
2022 Q1	$308K	Hold	1,900	–	–	0.17%	56
2021 Q4	$257K	Hold	1,900	–	–	0.13%	64
2021 Q3	$205K	Hold	1,900	–	–	0.11%	71
2021 Q2	$214K	Hold	1,900	–	–	0.12%	75
2021 Q1	$206K	Sell	1,900 -1,600	-46%	-$173K	0.12%	72
2020 Q4	$375K	Hold	3,500	–	–	0.24%	54
2020 Q3	$307K	Hold	3,500	–	–	0.22%	55
2020 Q2	$344K	Hold	3,500	–	–	0.25%	53
2020 Q1	$267K	Hold	3,500	–	–	0.22%	57
2019 Q4	$310K	Hold	3,500	–	–	0.17%	57
2019 Q3	$265K	Sell	3,500 -550	-14%	-$41.6K	0.15%	63
2019 Q2	$295K	Hold	4,050	–	–	0.16%	61
2019 Q1	$326K	Sell	4,050 -1,675	-29%	-$135K	0.18%	59
2018 Q4	$528K	Hold	5,725	–	–	0.33%	50
2018 Q3	$541K	Hold	5,725	–	–	0.29%	49
2018 Q2	$530K	Hold	5,725	–	–	0.28%	50
2018 Q1	$542K	Sell	5,725 -2,275	-28%	-$215K	0.29%	50
2017 Q4	$774K	Sell	8,000 -3,700	-32%	-$358K	0.39%	46
2017 Q3	$1.04M	Sell	11,700 -600	-5%	-$53.3K	0.54%	41
2017 Q2	$892K	Sell	12,300 -300	-2%	-$21.8K	0.5%	43
2017 Q1	$821K	Sell	12,600 -1,950	-13%	-$127K	0.46%	43
2016 Q4	$911K	Sell	14,550 -600	-4%	-$37.6K	0.5%	43
2016 Q3	$956K	Hold	15,150	–	–	0.52%	44
2016 Q2	$938K	Sell	15,150 -15,100	-50%	-$935K	0.54%	42
2016 Q1	$1.73M	Sell	30,250 -900	-3%	-$51.4K	0.97%	31
2015 Q4	$1.85M	Sell	31,150 -1,525	-5%	-$90.3K	1.04%	31
2015 Q3	$1.78M	Sell	32,675 -1,325	-4%	-$72.1K	1.04%	31
2015 Q2	$2.28M	Buy	34,000 +300	+0.9%	+$20.2K	1.18%	29
2015 Q1	$1.97M	Sell	33,700 -1,000	-3%	-$58.5K	1%	31
2014 Q4	$2.27M	Sell	34,700 -9,650	-22%	-$632K	1.08%	32
2014 Q3	$2.56M	Sell	44,350 -2,200	-5%	-$127K	1.19%	32
2014 Q2	$2.63M	Sell	46,550 -3,025	-6%	-$171K	1.17%	33
2014 Q1	$2.55M	Sell	49,575 -6,850	-12%	-$352K	1.12%	34
2013 Q4	$2.98M	Buy	56,425 +675	+1%	+$35.6K	1.29%	34
2013 Q3	$2.49M	Sell	55,750 -8,600	-13%	-$385K	1.15%	35
2013 Q2	$2.66M	Buy	+64,350	New	+$2.66M	1.27%	35